-
Study aim
-
The effect of Gababentin preoperative administration to prevent or reduce pain following laparoscopy of advanced endometriosis
-
Design
-
Clinical trial with control and intervention group, three blind strains, phase 3 on 140 patients with 70 patients in each group
-
Settings and conduct
-
This study was performed in women with endometriosis referred to Hazrat Rasool Akram Hospital in 1300-1400. 70 patients with endometriosis will be in the gabapentin treatment group and 70 patients with endometriosis will be in the control group. Written consent to participate in the study is obtained. Then, in the treatment group, 600 mg of gabapentin with 30 cc of water is given one hour before the operation, and in the control group, placebo is given that have the same packaging and color. Patients All patients involved in this study, including surgeons and anesthesiologists and nurses, are not aware of the type of drug given to the patient. All patients undergo general anesthesia and laryngeal intubation. The operation time and operation technique are the same for all patients.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria: All patients with endometriosis aged 16-40 years in Stage 3 and 4 diseases.
Exclusion criteria: Kidney and liver patients, patients with gabapentin allergy, patients with mental disorders and epilepsy, as well as patients who have taken painkillers and any drugs and cigarettes one week before surgery
-
Intervention groups
-
70 patients with endometriosis will be in the gabapentin treatment group and 70 patients with endometriosis will be in the control group. Then, in the treatment group, 600 mg of gabapentin with 30 cc of water is given one hour before the operation, and in the control group, placebo is given that have the same packaging and color.
-
Main outcome variables
-
Reducing pain and reducing postoperative drug use using a single dose of gabapentin before surgery